Ascendent Capital Partners has completed the sale of Suzhou Yongding Hospital to Hygeia Healthcare, enhancing its position in the oncology services market in a growing region of China.

Information on the Target

Suzhou Yongding Hospital is a premier general hospital offering an extensive range of services that includes medical care, education, research, disease prevention, sanatorium, and rehabilitation. With a large footprint of 65,000 square meters and a capacity of 1,000 beds, it stands as the largest privately-owned hospital in the region. Over the past decade, Yongding Hospital has successfully established a stable operation and comprehensive healthcare network, effectively serving 1.3 million residents.

Industry Overview in China

The healthcare industry in China has experienced significant transformations and investments in recent years, driven by rising consumer demand for quality services and government initiatives aimed at improving healthcare infrastructure. The country acknowledges the urgent need for enhanced medical capabilities, particularly in specialized fields like oncology. This has led to a surge in the establishment of general and specialized hospitals that cater to the growing population and demands.

In addition to its rising healthcare needs, China faces challenges such as uneven distribution of healthcare resources and insufficient access to advanced medical services in certain regi

View Source

Similar Deals

AstraZeneca FiberGen

2025

Buyout Proprietary & Advanced Pharmaceuticals China
Novartis SanReno Therapeutics

2024

Buyout Proprietary & Advanced Pharmaceuticals China
GL Capital SciClone Pharmaceuticals

2023

Buyout Proprietary & Advanced Pharmaceuticals China
GL Capital Group Huizhou Foryou Medical Devices Co., Ltd

2023

Buyout Medical Devices & Implants China

Hygeia Healthcare

invested in

Suzhou Yongding Hospital

in 2021

in a Buyout deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert